ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 219,14
0,38%
Dow Jones
39 512,84
0,32%
DAX
18 772,85
0,50%
Brent Oil
82,585
-1,63%
Bitcoin
60 509,17
-4,03%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Brickell Biotech Inc (BBI)

  7. Brickell Biotech Inc (BBI) Actualités

BBI

Brickell Biotech (BBI)

Brickell Biotech Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:BBI
DateHeureSourceTitreSymboleSociété
10/05/202322h05Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:BBIBrickell Biotech Inc
01/05/202322h44Edgar (US Regulatory)Amended Annual Report (10-k/a)NASDAQ:BBIBrickell Biotech Inc
22/02/202322h04Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:BBIBrickell Biotech Inc
13/02/202323h25Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:BBIBrickell Biotech Inc
27/01/202300h50Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:BBIBrickell Biotech Inc
14/11/202212h07Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:BBIBrickell Biotech Inc
12/09/202212h02Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BBIBrickell Biotech Inc
06/09/202222h44Edgar (US Regulatory)Seperately Filed Delaying Amendment Under Securities Act Rule 473 to Delay Effectiveness of a 1933 Act Registration Statement (del Am)NASDAQ:BBIBrickell Biotech Inc
02/09/202222h08Edgar (US Regulatory)Securities Registration Statement (s-1)NASDAQ:BBIBrickell Biotech Inc
23/06/202222h07Edgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:BBIBrickell Biotech Inc
22/06/202212h03Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:BBIBrickell Biotech Inc
17/06/202215h02Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:BBIBrickell Biotech Inc
07/06/202222h29Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:BBIBrickell Biotech Inc
27/05/202214h59Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:BBIBrickell Biotech Inc
24/05/202223h17Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:BBIBrickell Biotech Inc
15/03/202212h48Edgar (US Regulatory)Annual Report (10-k)NASDAQ:BBIBrickell Biotech Inc
28/10/202123h21Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BBIBrickell Biotech Inc
03/09/202114h01Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:BBIBrickell Biotech Inc
22/07/202115h00Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:BBIBrickell Biotech Inc
19/07/202123h27Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:BBIBrickell Biotech Inc
15/03/202113h05Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:BBIBrickell Biotech Inc
09/03/202122h29Edgar (US Regulatory)Securities Registration Statement (simplified Form) (s-3)NASDAQ:BBIBrickell Biotech Inc
22/10/202012h11Edgar (US Regulatory)Securities Registration Statement (s-1/a)NASDAQ:BBIBrickell Biotech Inc
24/09/202021h47Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:BBIBrickell Biotech Inc
13/08/202023h20Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:BBIBrickell Biotech Inc
03/08/202022h05GlobeNewswire Inc.Brickell Biotech to Report Second Quarter 2020 Financial Results and Provide a Corporate Update on August 12, 2020NASDAQ:BBIBrickell Biotech Inc
18/06/202004h00GlobeNewswire Inc.Brickell Biotech, Inc. Announces Pricing of $20.1 Million Underwritten Public OfferingNASDAQ:BBIBrickell Biotech Inc
15/06/202012h30GlobeNewswire Inc.Brickell Biotech Announces Positive Phase 3 Pivotal Study Results for Sofpironium Bromide in Japan Released by Development Pa...NASDAQ:BBIBrickell Biotech Inc
13/05/202022h01GlobeNewswire Inc.Brickell Biotech Reports First Quarter 2020 Financial Results and Provides Corporate UpdateNASDAQ:BBIBrickell Biotech Inc
04/05/202022h05GlobeNewswire Inc.Brickell Biotech to Report First Quarter 2020 Financial Results on May 13, 2020NASDAQ:BBIBrickell Biotech Inc
 Showing the most relevant articles for your search:NASDAQ:BBI

Dernières Valeurs Consultées

NASDAQ
NVDA
NVIDIA
SPI
SP500
S&P 500
EU
BN
Danone
EU
CS
Axa
NYSE
KO
Coca Cola
EU
LR
Legrand
EU
PX4
SBF 120
NYSE
JPM
JP Morgan Chase
EU
ACA
Credit Agricole
EU
VIV
Vivendi
COIN
ETHUSD
Ethereum
EU
VK
Vallourec
NASDAQ
AMZN
Amazon.com
EU
ML
Michelin
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés